Skip to main content

  • IBEC researchers use "mini-kidneys" to study one of the pathways that SARS-Co-V2 virus uses to enter our body

    27 Mar, 2020

    IBEC researchers work in collaboration with experts from Sweden, Canada and Austria who are working intensively these days to validate the effect of possible treatments that may slow or attenuate the ability of the virus to replicate in our body.

    The fact that experts from all over the world have now reached to IBEC researchers is because groups such as the one led by Núria Montserrat are pioneers in the use of bioengineering techniques to create mini-organs that, like the respirat...
  • Prisma Health introduces an open source Ventilator Expansion device!

    27 Mar, 2020
    VESper™ is a new device that allows one ventilator to support up to four patients under emergency use authorization by the FDA. Hospitals can apply to receive the free source code and printing specifications for the device.



    VESper™ is a unique ventilator expansion device that allows a single ventilator to support up to four patients during times of acute equipment shortages such as the current COVID-19 pandemic.

    Produced using 3D printing technology, the device is develo...
  • Nature publishes: Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2

    27 Mar, 2020


    Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2Abstract



    Human coronaviruses (HCoVs), including severe acute respiratory syndrome coronavirus (SARS-CoV) and 2019 novel coronavirus (2019-nCoV, also known as SARS-CoV-2), lead global epidemics with high morbidity and mortality. However, there are currently no effective drugs targeting 2019-nCoV/SARS-CoV-2. Drug repurposing, representing as an effective drug discovery strategy from existing drugs, c...
  • Modelling study estimates impact of physical distancing measures on progression of COVID-19 epidemic in Wuhan

    26 Mar, 2020
    New modelling research, published in The Lancet Public Health journal, suggests that school and workplace closures in Wuhan, China have reduced the number of COVID-19 cases and substantially delayed the epidemic peak - giving the health system the time and opportunity to expand and respond.

    Using mathematical modelling to simulate the impact of either extending or relaxing current school and workplace closures, researchers estimate that by lifting these control measures in March, a sec...
  • Look inside the hospital in China where coronavirus patients were treated by robots

    26 Mar, 2020

    The idea of humanoid robots taking jobs previously done by humans may feel dystopian, but in the midst of the global COVID-19 pandemic, robots can free up human hospital medical staff and limit the possibility virus spread.

    That’s precisely why Beijing-based robotics company CloudMinds sent 14 robots to Wuhan, China to help with patient care amid the coronavirus pandemic. 
    Click here for reference


  • COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission

    26 Mar, 2020
    Current studies reveal that respiratory symptoms of COVID-19 such as fever, dry cough, even dyspnea represent the most common manifestations at visit similar to severe acute respiratory syndrome (SARS) in 2003 and Middle East respiratory syndrome (MERS) in 2012, which is firmly indicative of droplet transmission and contact transmission. However, the incidence of less common features like diarrhea, nausea, vomiting and abdominal discomfort varies significantly among different study popu...
  • Coronavirus: Spain’s death toll surpasses China’s

    26 Mar, 2020
    Spain’s death toll from the coronavirus has surpassed the official figure from China, becoming the second highest in the world.
    Figures released by the health ministry on Wednesday showed that in just 24 hours, Spain’s national death toll rose by 738. Its number of cases soared by 7,973.These are the highest figures for Spain in a single day. The country now has 47,610 confirmed cases.Click here for reference




  • Liver injury in COVID-19: management and challenges

    26 Mar, 2020
    SARS-CoV-2 shares 82% genome sequence similarity to SARS-CoV and 50% genome sequence homology to Middle East respiratory syndrome coronavirus (MERS-CoV)—all three coronaviruses are known to cause severe respiratory symptoms. Liver impairment has been reported in up to 60% of patients with SARS3 and has also been reported in patients infected with MERS-CoV.4 At least seven relatively large-scale case studies have reported the clinical features of patients with COVID-19.
    In this Co...
  • You can help fight the coronavirus. All you need is a computer!

    26 Mar, 2020

    The Folding@home initiative aims to simulate the dynamics of COVID-19 proteins to hunt for new therapeutic opportunities.

    Their specialty is in using computer simulations to understand proteins’ moving parts. Watching how the atoms in a protein move relative to one another is important because it captures valuable information that is inaccessible by any other means. Taking the experimental structures as starting points, they simulate how all the atoms in the protein move, effective...
  • COVID-19 pandemic: triage for intensive-care treatment under resource scarcity

    26 Mar, 2020
    Owing to the rapid spread of the coronavirus (SARS-CoV-2), an extraordinary situation has been declared,1 and acute hospitals will therefore be confronted with a massive influx of patients. Initially, this can be absorbed by the restriction of elective procedures,2 the transfer of patients to intermediate care units (IMCUs), an increase in ventilator-equipped beds, and the avoidance of personnel-intensive treatment options. However, if insufficient resources are available, rationing decisions...
  • Spain's Grifols to Test Plasma Therapy for COVID-19 With U.S. FDA

    26 Mar, 2020

    Spain's Grifols has agreed to work with the U.S. Food and Drug Administration and other agencies to gather plasma from patients who have recovered from COVID-19 and test potential therapies for the disease, the pharmaceutical firm said on Wednesday.

    The plasma will be processed to produce hyperimmune immunoglobins, which will then be put to pre-clinical and clinical tests to see if they can help treat the disease, Grifols said in a statement.

    COVID-19 is caused by the corona...
  • NEW STRATEGIES IN COLORECTAL MANAGEMENT

    25 Mar, 2020




    SAVE THE DATE
    MARCH 27th
    8:00PM | Beijing time
    Watch live FREE at www.aischannel.com


    PROGRAM

    Welcome & Introduction
    · Prof. Antonio de Lacy - Hospital Clinic of Barcelona, Chief of Gastrointestinal Dept. of Surgery· Prof. Zhongtao Zhang (China) - Beijing Friendship Hospital, President of Chinese Society of Colorectal Surgery (CNSCRS)


    Current situation of colorectal cancer around the world with COVID19. Indications to operate ...